Clinical Trial

Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)

Name: Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS) — clinical trial record (NCT07604220)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: EXODACS

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.

Trial Details

NCT Number	NCT07604220
Lead Sponsor	Mayo Clinic
Conditions	Cardiac Sarcoidosis, Sarcoidosis of the Heart, Sarcoidosis With Myocarditis, Sarcoidosis, Cardiac
Enrollment	115 participants
Start Date	2026-07
Primary Completion	2028-07 (estimated)
Study Completion	2028-07 (estimated)
Updated on ClinicalTrials.gov	2026-05-22